Skip to main content

Advertisement

SpringerLink
Log in

Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Natural bioactive compounds have increasingly proved to be promising in evidence- or target-directed treatment or modification of a spectrum of diseases including cerebral ischemic stroke. Hydroxysafflor yellow A (HSYA), a major active component of the safflower plant, has drawn more interests in recent year for its multiple pharmacological actions in the treatment of cerebrovascular and cardiovascular diseases. Although the Janus kinase signaling, such as JAK2/STAT3 pathway, has been implicated in the modulation of the disease, the inhibition or activation of the pathway that contributed to the neuronal prevention from ischemic damages remains controversial. In this study, a series of experiments were performed to examine the dose- and therapeutic time window-related pharmacological efficacies of HSYA with emphasis on the HSYA-modulated interaction of JAK2/STAT3 and SOCS3 signaling in the MCAO rats. We found that HSYA treatment significantly rescued the neurological and functional deficits in a dose-dependent manner in the MCAO rats within 3 h after ischemia. HSYA treatment with a dosage of 8 mg/kg or higher markedly downregulated the expression of the JAK2-mediated signaling that was activated in response to ischemic insult, while it also promoted the expression of SOCS3 coordinately. In the subsequent experiments with the use of the JAK2 inhibitor WP1066, we found that the treatment of WP1066 alone or combination of WP1066/HSYA all exhibited inhibitory effects on JAK2-mediated signaling, while there was no influence on the SOCS3 activity of corresponding efficacious data in the MCAO rats, suggesting that excessive activation of JAK2/STAT3 might be necessary for HSYA to provoke SOCS3-negative feedback signaling. Taking together, our study demonstrates that HSYA might modulate the crosstalk between JAK2/STAT3 and SOCS3 signaling pathways that eventually contributed to its therapeutic roles against cerebral ischemic stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Bacigaluppi M, Comi G, Hermann DM (2010) Animal models of ischemic stroke part two: modeling cerebral ischemia. Open Neurol J 4:34–38

    PubMed  PubMed Central  Google Scholar 

  • Baggiolini M (1995) Guidebook to cytokines and their receptors. FEBS Lett 369:347–348

    CAS  Google Scholar 

  • Chao J, Dai Y, Verpoorte R, Lam W, Cheng YC, Pao LH, Zhang W, Chen S (2017) Major achievements of evidence-based traditional Chinese medicine in treating major diseases. Biochem Pharmacol 139:94–104

    CAS  PubMed  Google Scholar 

  • Chen YC, Wu JS, Yang ST, Huang CY, Chang C, Sun GY, Lin TN (2012) Stroke, angiogenesis and phytochemicals. Front Biosci 4:599–610

    CAS  Google Scholar 

  • Chen L, Xiang Y, Kong L, Zhang X, Sun B, Wei X, Liu H (2013) Hydroxysafflor yellow A protects against cerebral ischemia–reperfusion injury by anti-apoptotic effect through pi3k/akt/gsk3β pathway in rat. Neurochem Res 38:2268–2275

    PubMed  Google Scholar 

  • Chen HS, Qi SH, Shen JG (2015) One-compound-multi-target: combination prospect of natural compounds with thrombolytic therapy in acute ischemic stroke. Curr Neuropharmacol 15:134–156

    Google Scholar 

  • Christophe BR, Mehta SH, Garton ALA, Sisti J (2017) Current and future perspectives on the treatment of cerebral ischemia. Expert Opin Pharmacother 18:573–580

    CAS  PubMed  Google Scholar 

  • Darnell JE, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to ifns and other extracellular signaling proteins. Science 264:1415–1421

    CAS  PubMed  Google Scholar 

  • Demers G, Meurer WJ, Shih R, Rosenbaum S, Vilke GM (2012) Tissue plasminogen activator and stroke: review of the literature for the clinician. J Emerg Med 43:1149–1154

    PubMed  Google Scholar 

  • D'Ippolito S, Marana R, Nicuolo FD, Castellani R, Veglia M, Stinson J, Scambia G, Simone ND (2012) Effect of low molecular weight heparins (LMWHs) on antiphospholipid antibodies (aPL)-mediated inhibition of endometrial angiogenesis. PLoS ONE 7(1):29660

    Google Scholar 

  • Dong W, Xian Y, Yuan W, Huifeng Z, Tao W, Zhiqiang L, Shan F, Ya F, Hongli W, Jinghuan W (2016) Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats stroke model. J Ethnopharmacol 191:169–179

    CAS  PubMed  Google Scholar 

  • Feng ZM, He J, Jiang JS, Chen Z, Yang YN, Zhang PC (2013) NMR solution structure study of the representative component hydroxysafflor yellow A and other quinochalcone c-glycosides from carthamus tinctorius. J Nat Prod 76:270–274

    CAS  PubMed  Google Scholar 

  • Garcia JH, Wagner S, Liu KF, Hu XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stat Valid Stroke 26:627–634

    CAS  Google Scholar 

  • Gertz K, Kronenberg G, Kälin RE, Baldinger T, Werner C, Balkaya M, Eom GD, Hellmannregen J, Kröber J, Miller KR (2012) Essential role of interleukin-6 in post-stroke angiogenesis. Brain 135:1964–1980

    PubMed  PubMed Central  Google Scholar 

  • Guo S, Li ZZ, Gong J, Xiang M, Zhang P, Zhao GN, Li M, Zheng A, Zhu X, Lei H (2015) Oncostatin m confers neuroprotection against ischemic stroke. J Neurosci 35:12047–12062

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hatashita S, Hoff JT, Salamat SM (1988) Ischemic brain edema and the osmotic gradient between blood and brain. J Cereb Blood Flow Metab 8:552–559

    CAS  PubMed  Google Scholar 

  • Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müllernewen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1–20

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jia L, Wang F, Gu X, Weng Y, Sheng M, Wang G, Li S, Du H, Yu W (2017) Propofol postconditioning attenuates hippocampus ischemia-reperfusion injury via modulating JAK2/STAT3 pathway in rats after autogenous orthotropic liver transplantation. Brain Res 1657:202–207

    CAS  PubMed  Google Scholar 

  • Jiang JS, He J, Feng ZM, Zhang PC (2010) Two new quinochalcones from the florets of carthamus tinctorius. Org Lett 12:1196–1199

    CAS  PubMed  Google Scholar 

  • Jin Y, Zhang XL, Shi H, Xiao YS, Ke YX, Xue XY, Zhang FF, Liang XM (2008) Characterization of C-glycosyl quinochalcones in carthamus tinctorius L. by ultraperformance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. Rapid Commun Mass Spectrom Rcm 22:1275–1287

    CAS  PubMed  Google Scholar 

  • Kershaw NJ, Murphy JM, Lucet IS, Nicola NA, Babon JJ (2013) Regulation of janus kinases by SOCS proteins. Biochem Soc T 41:1042–1047

    CAS  Google Scholar 

  • Krebs DL, Hilton DJ (2000) SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113(Pt 16):2813–2819

    CAS  PubMed  Google Scholar 

  • Kubo M, Hanada T, Yoshimura A (2003) Suppressors of cytokine signaling and immunity. Nat Immunol 4:1169–1176

    CAS  PubMed  Google Scholar 

  • Kwon O, Kim KW, Kim MS (2016) Leptin signalling pathways in hypothalamic neurons. Cell Mol Life Sci 73:1457–1477

    CAS  PubMed  Google Scholar 

  • Li S, Li Y, Ying F, Jing H, Xu Y, Hao L, Yan C (2013) Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury. Nitric Oxide Biol Chem 35:144–151

    CAS  Google Scholar 

  • Li H, Wu J, Shen H, Yao X, Liu C, Pianta S, Han J, Borlongan CV, Chen G (2017a) Autophagy in hemorrhagic stroke: mechanisms and clinical implications. Prog Neurobiol 163–164:79–97

    PubMed  Google Scholar 

  • Li Y, Zhang X, Cui L, Rong C, Ye Z, Cong Z, Zhu X, He T, Shen Z, Dong L (2017b) Salvianolic acids enhance cerebral angiogenesis and neurological recovery by activating JAK2/STAT3 signaling pathway after ischemic stroke in mice. J Neurochem 143:87–99

    CAS  PubMed  Google Scholar 

  • Liu Z, Li C, Li M, Li D, Liu K (2004) The subchronic toxicity of hydroxysafflor yellow A of 90 days repeatedly intraperitoneal injections in rats. Toxicology 203:139–143

    CAS  PubMed  Google Scholar 

  • Liu X, Zhang X, Zhang J, Kang N, Zhang N, Wang H, Xue J, Yu J, Yang Y, Cui H (2014) Diosmin protects against cerebral ischemia/reperfusion injury through activating JAK2/STAT3 signal pathway in mice. Neuroscience 268:318–327

    CAS  PubMed  Google Scholar 

  • Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91

    CAS  PubMed  Google Scholar 

  • Lv Y, Qian Y, Fu L, Chen X, Zhong H, Wei X (2015) Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune tlr4-inducing pathway. Eur J Pharmacol 769:324–332

    CAS  PubMed  Google Scholar 

  • Mengya X, Qingna S, Yiyi W, Yan C, Nan Z (2016) Hydroxysafflor yellow A increases BDNF and NMDARs in the hippocampus in a vascular dementia rat model. Brain Res 1642:419–425

    Google Scholar 

  • O’Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Ann Rev Med 66:311–328

    PubMed  Google Scholar 

  • Raible DJ, Frey LC, Brooks-Kayal AR (2014) Effects of JAK2-STAT3 signaling after cerebral insults. JAK-STAT 3:e29510

    PubMed  PubMed Central  Google Scholar 

  • Redondoblanco S, Fernández J, Gutiérrezdelrío I, Villar CJ, Lombó F (2017) New insights toward colorectal cancer chemotherapy using natural bioactive compounds. Front Pharmacol 8:109

    Google Scholar 

  • Satriotomo I, Bowen KK, Vemuganti R (2006) JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 98:1353–1368

    CAS  PubMed  Google Scholar 

  • Shan LQ, Ma S, Qiu XC, Zhou Y, Zhang Y, Zheng LH, Ren PC, Wang YC, Fan QY, Ma BA (2010) Hydroxysafflor yellow A protects spinal cords from ischemia/reperfusion injury in rabbits. BMC Neuroscience 11:1–8

    Google Scholar 

  • Shyu WC, Lin SZ, Chiang MF, Chen DC, Su CY, Wang HJ, Liu RS, Tsai CH, Li H (2008) Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Investig 118:133–148

    CAS  PubMed  Google Scholar 

  • Suganami E, Takagi H, Ohashi H, Suzuma K, Suzuma I, Oh H, Watanabe D, Ojima T, Suganami T, Fujio Y (2004) Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 53:2443–2448

    CAS  PubMed  Google Scholar 

  • Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A (2011) Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 31:980–985

    CAS  PubMed  Google Scholar 

  • Tian J, Li G, Liu Z, Fu F (2008) Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action. Pharmacology 82:121–126

    CAS  PubMed  Google Scholar 

  • Villarino AV, Kanno Y, O'Shea JJ (2017) Mechanisms and consequences of JAK-STAT signaling in the immune system. Nat Immunol 18:374–384

    CAS  PubMed  Google Scholar 

  • Wang G, Zhou D, Wang C, Gao Y, Zhou Q, Qian G, Decoster MA (2010) Hypoxic preconditioning suppresses group III secreted phospholipase A2-induced apoptosis via JAK2-STAT3 activation in cortical neurons. J Neurochem 114:1039–1048

    CAS  PubMed  Google Scholar 

  • Wang XL, Qiao CM, Liu JO, Li CY (2017) Inhibition of the SOCS1-JAK2-STAT3 signaling pathway confers neuroprotection in rats with ischemic stroke. Cell Physiol Biochem 44:85–98

    PubMed  Google Scholar 

  • Wardlaw JM, Murray V, Berge E, Del ZG, Sandercock P, Lindley RL, Cohen G (2012) Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–2372

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wei X, Liu H, Sun X, Fu F, Zhang X, Wang J, An J, Ding H (2005) Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci Lett 386:58–62

    CAS  PubMed  Google Scholar 

  • Wunderlich CM, Hövelmeyer N, Wunderlich FT (2013) Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAK-STAT 2:e23878

    PubMed  PubMed Central  Google Scholar 

  • Zhang Z, Wu Z, Zhu X, Hui X, Pan J, Xu Y (2014) Hydroxy-safflor yellow a inhibits neuroinflammation mediated by Aβ1-42 in BV-2 cells. Neurosci Lett 562:39–44

    CAS  PubMed  Google Scholar 

  • Zhu H, Zou L, Tian J, Du G, Gao Y (2013) SMND-309, a novel derivative of salvianolic acid B, protects rat brains ischemia and reperfusion injury by targeting the JAK2/STAT3 pathway. Eur J Pharmacol 714:23–31

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from the National Natural Science Foundation of China (81503370 to LY, 31171019 to ZZ and 81470829 to JZ), Shanghai Natural Science Foundation (19ZR1447900 to LY), and MOST China–Israel Cooperation (2016YFE0130500 to XHC), and an opening grant from Key Laboratory of Brain Functional Genomics (ECNU), Ministry of Education, ECNU (JZ).

Author information

Author notes

  1. Lu Yu, Zhili Liu and Wendi He have contributed equally to this work.

Authors and Affiliations

  1. Comprehensive Department of Traditional Chinese Medicine, Putuo Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China

    Lu Yu & Jie Tao

  2. Key Laboratory of Brain Functional Genomics (East China Normal University), Ministry of Education, School of Life Sciences, East China Normal University, Shanghai, 200062, China

    Zhili Liu, Wendi He, Zelin Lai, Yanhong Duan, Xiaohua Cao & Zheng Zhao

  3. Department of Clinical Laboratory, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, 201204, China

    Huifen Chen & Jun Zhang

  4. Department of Neurology, Yueyang Hospital of Integrated Chinese and Western Medicine, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China

    Chuan Xu & Qiujuan Zhang

Authors
  1. Lu Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhili Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wendi He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huifen Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zelin Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yanhong Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaohua Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jie Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chuan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Qiujuan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Zheng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LY, ZLL, WDH, XHC, QJZ, ZZ, and JZ conceived the project, planned the experiments, and analyzed and interpreted the data with support from HFC, ZLL, YHD, JT, and CX. LY, ZLL, WDH, HFC, ZLL, JT, and CX performed all experiments. LY, ZLL, WDH, QJZ, ZZ, and JZ prepared and reviewed the manuscript. All authors contributed to and approved the final manuscript.

Corresponding authors

Correspondence to Qiujuan Zhang, Zheng Zhao or Jun Zhang.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving animals were in accordance with NIH Animal Welfare Act guidance and were approved by the Institutional Animal Care and Use Committee (IACUC approval ID #M07016) of the East China Normal University.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, L., Liu, Z., He, W. et al. Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways. Cell Mol Neurobiol 40, 1271–1281 (2020). https://doi.org/10.1007/s10571-020-00812-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-020-00812-7

Keywords

Search

Navigation